Semathera
SemaThera develops inhibitors against semaphorin 3A for prevention and reversal of diabetic macular edema.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Semathera Information
Geographic Data
Address: 800-1 Westmount Square
City: Montreal
State: quebec
Zip: H3Z 2P9
Country: CA
Financial Info
Stage:
series unknown
Raised Last:
$3M
Raised Total:$2M
Social
Metrics
5,422,007Website Global Rank
1,558Website Monthly Traffic
Twitter Followers
Description
SemaThera develops inhibitors against semaphorin 3A for prevention and reversal of diabetic macular edema.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2017 | Seed Round | $1M | 3/2018 | Venture Round | 2 | $2.6M |
Amorchem Senju Pharmaceutical Amorchem Senju Pharmaceutical |
3/2018 | Equity | $2M |
Senju Pharmaceutical Co., AmorChem L.P |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
